We've strayed far from the Dr. Marcus Welby persona -- in popular television, at least. But even Dr. Gregory House, the irascible main character in the Fox television drama, has moments of compassion. 

In real life, compassion is still very much an important part of a physician's practice. And there is perhaps no clearer example of a physician's need for compassion than in the treatment of headaches. 

Paul Mueller was awarded the American Heart Association (AHA) Atherosclerosis Thrombosis and Vascular Biology (ATVB) Travel Award for Young Investigators.  The international meeting will be held in Chicago at the upcoming American Heart Association Scientific Sessions. This award recognizes meritorious work by young investigators in training, encourages participation in the AHA Scientific Sessions, and provides a stipend to help defer travel expenses to present their work at the AHA Scientific Sessions.

There is a phone call Point of Care Ultrasound Director and Assistant Emergency Medicine Program Director Dr. Matthew Dawson will never forget. 

While he was a medical resident in Utah, his father Stewart Dawson, then the chaplain for theLexington Fire Department, called to ask him about a bispectral index monitor – more commonly called a BIS monitor.    

NIH recently updated policies regarding application submissions.  That update allowed resubmission of an A1 application as an A0.  One of the restrictions outlined in the policy update states that the second A0 submission can not reference any previous reviews.  NIH is rejecting any application making reference to previous reviews.  To read more of the policy, click here.  For questions, contact your GPS.

[From NIH eSubmission Items of Interest - September 18, 2014]

Systematic Application Compliance Checking – What It Is and What It’s Not 

Automated enforcement of business rules by NIH eRA systems plays an important role in the application submission process – it helps you and it helps NIH. Understanding what that role covers can be the difference between your application moving forward to review and not. 

System-enforced application validations are what they are – nothing more, nothing less. 

In response to the third cycle of NCI Alliance activity, we are organizing a team to work on a proposal for  “NCI Center for Cancer Nanotechnology Excellence”. The UK proposal is entitled  “RNA Nanotechnology Center for Cancer Therapy".   We strongly encourage UK faculties to participate in this proposal.  Please contact Peixuan Guo (peixuan.guo@uky.edu) for a recommendation to a project leader.  The deadline is the beginning of November.

Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies.
Heart. 2014 Oct 1;100(19):1498-1505. doi: 10.1136/heartjnl-2014-305648. Epub 2014 Jul 24.
Davis FM, Rateri DL, Daugherty A.
PMID:25060754

Abstract: